|
"pu y s"的相關文件
顯示項目 566-590 / 627 (共26頁)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-01-23T01:37:23Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.;Chiang C.-H.;Pu Y.-S.;Liu S.P.;Lu Y.-C.;Chang Y.-K.;Chang H.-C.;Huang K.-H.;Lee Y.-J.;Po-Ming Chow;Hung S.-C.;Huang C.-Y.; Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; Lee Y.-J.; PO-MING CHOW; Hung S.-C.; Huang C.-Y. |
| 臺大學術典藏 |
2020-01-23T01:37:22Z |
Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral center
|
Chen C.-H.; Chiang I.-N.; Lu Y.-C.; Hung S.-C.; Huang K.-H.; Huang C.-Y.; Chang H.-C.; Pu Y.-S.; PO-MING CHOW; Hong C.-H.; Tseng C.-S.; Tai T.-E.; Tseng C.-S.;Tai T.-E.;Hong C.-H.;Chen C.-H.;Chiang I.-N.;Lu Y.-C.;Hung S.-C.;Huang K.-H.;Huang C.-Y.;Chang H.-C.;Pu Y.-S.;Po-Ming Chow |
| 臺大學術典藏 |
2020-01-22T07:50:53Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; CHI-AN CHEN; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y.; Lin J.-K.; Hsu C.-H.; Chen A.-L.; Chen A.-L.;Hsu C.-H.;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chi-An Chen;Lai M.-K.;Pu Y.-S.;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Hsieh C.-Y. |
| 臺大學術典藏 |
2020 |
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
|
Chiang C.-H.; Hung S.-C.; Chiang I.-N.; Chow P.-M.; Lee Y.-J.; Chang H.-C.; Huang K.-H.; Chang Y.-K.; YU-CHUAN LU; Liu S.-P.; Pu Y.-S.; Hong J.-H.; Chiu S.-T.; Chen C.-H.; Huang C.-Y.; Cheng Y.-T. |
| 國立成功大學 |
2020 |
United in Fight against prOstate cancer (UFO) registry: first results from a large, multi-centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia
|
Uemura, H.;Ye, D.;Kanesvaran, R.;Chiong, E.;Lojanapiwat, B.;Pu, Y.-S.;Rawal, S.K.;Abdul, Razack A.H.;Zeng, H.;Chung, B.H.;Md, Yusoff N.A.;Ohyama, C.;Kim, C.S.;Leewansangtong, S.;Tsai, Y.-S.;Liu, Y.;Liu, W.;van, Kooten Losio M.;Asinas-Tan, M. |
| 臺大學術典藏 |
2019-11-12T07:36:33Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
Lin W.-C.;Kuo K.-L.;Shi C.-S.;Wu J.-T.;Hsieh J.-T.;Chang H.-C.;Liao S.-M.;Chou C.-T.;Chiang C.-K.;Chiu W.-S.;Chiu T.-Y.;Pu Y.-S.;Ho I.-L.;Wang Z.-H.;Chang S.-C.;Shing-Hwa Liu;Jeng Y.-M.;Huang K.-H.; Lin W.-C.; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C.; Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; SHING-HWA LIU; Jeng Y.-M.; Huang K.-H. |
| 臺大學術典藏 |
2019 |
Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral center
|
Chow P.-M.;Pu Y.-S.;Chang H.-C.;Huang C.-Y.;Huang K.-H.;Hung S.-C.;YU-CHUAN LU;Chiang I.-N.;Chen C.-H.;Hong C.-H.;Tai T.-E.;Tseng C.-S.; Tseng C.-S.; Tai T.-E.; Hong C.-H.; Chen C.-H.; Chiang I.-N.; YU-CHUAN LU; Hung S.-C.; Huang K.-H.; Huang C.-Y.; Chang H.-C.; Pu Y.-S.; Chow P.-M. |
| 臺大學術典藏 |
2019 |
Nuclear factor-�eB overexpression is correlated with poor outcomes after multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer
|
Cheng J.C.-H.; Lin C.-C.; Pu Y.-S.; Huang C.-Y.; YU-CHIEH TSAI; Wang C.-C.; Chiang Y. |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma
|
Huang, C.-Y.;Lin, Y.-C.;Shiue, H.-S.;Chen, W.-J.;Su, C.-T.;Pu, Y.-S.;Ao, P.-L.;Hsueh, Y.-M.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
Impact of high-volume disease in Asian population with newly diagnosed metastatic prostate cancer
|
Cheng, Y.-T.;Hong, J.-H.;Lu, Y.-C.;Pu, Y.-S.;Huang, C.-Y.;Huang, K.-H.;Liu, S.;Chen, C.-H.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
|
Springer, S.U.;Chen, C.-H.;Del Carmen Rodriguez Pena, M.;Li, L.;Douville, C.;Wang, Y.;Cohen, J.D.;Taheri, D.;Silliman, N.;Schaefer, J.;Ptak, J.;Dobbyn, L.;Papoli, M.;Kinde, I.;Afsari, B.;Tregnago, A.C.;Bezerra, S.M.;Vandenbussche, C.;Fujita, K.;Ertoy, D.;Cunha, I.W.;Yu, L.;Bivalacqua, T.J.;Grollman, A.P.;Diaz, L.A.;Karchin, R.;Danilova, L.;Huang, C.-Y.;Shun, C.-T.;Turesky, R.J.;Yun, B.H.;Rosenquist, T.A.;Pu, Y.-S.;Hruban, R.H.;Tomasetti, C.;Papadopoulos, N.;Kinzler, K.W.;Vogelstein, B.;Dickman, K.G.;Netto, G.J.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
Outcomes of prostate atypical small acinar proliferation and high-grade prostate intraepithelial neoplasm patients
|
Tung, S.-Y.;Pu, Y.-S.;Huang, C.-Y.;Chang, H.-C.;Huang, K.-H.;Wang, S.-M.;Tai, H.-C.;Chen, C.-H.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
Polymorphisms of TNF-�\ -308 G/A and IL-8 -251 T/A Genes Associated with Urothelial Carcinoma: A Case-Control Study
|
Wu, C.-C.;Huang, Y.-K.;Huang, C.-Y.;Shiue, H.-S.;Pu, Y.-S.;Su, C.-T.;Lin, Y.-C.;Hsueh, Y.-M.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng, Y.-T.;Chiang, C.-H.;Pu, Y.-S.;Liu, S.P.;Lu, Y.-C.;Chang, Y.-K.;Chang, H.-C.;Huang, K.-H.;Lee, Y.-J.;Chow, P.-M.;Hung, S.-C.;Huang, C.-Y.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:38Z |
Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma
|
Hsueh, Y.-M.;Chen, W.-J.;Lin, Y.-C.;Huang, C.-Y.;Shiue, H.-S.;Yang, S.-M.;Ao, P.-L.;Pu, Y.-S.;Su, C.-T.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T15:34:59Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Chiang, Y.;Cheng, J.C.H.;Huang, C.-Y.;Tsai, Y.-C.;Lin, C.-C.;Hsu, C.-H.;Cheng, A.-L.;Pu, Y.-S.; CHAO-YUAN HUANG; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T15:34:59Z |
Analysis of transrectal and suprapubic ultrasonography for prostate size evaluation
|
Feng, K.-K.;Chiang, I.-N.;Huang, C.-Y.;Pu, Y.-S.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T15:34:14Z |
Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma
|
Yang, S.-M.;Huang, C.-Y.;Shiue, H.-S.;Pu, Y.-S.;Hsieh, Y.-H.;Chen, W.-J.;Lin, Y.-C.;Hsueh, Y.-M.; Yang, S.-M.; Huang, C.-Y.; Shiue, H.-S.; Pu, Y.-S.; Hsieh, Y.-H.; Chen, W.-J.; Lin, Y.-C.; Hsueh, Y.-M.; CHAO-YUAN HUANG; YEONG-SHIAU PU; Chen, Wei-Jen |
| 臺大學術典藏 |
2018-09-10T15:28:01Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
Lin, W.-C.;Kuo, K.-L.;Shi, C.-S.;Wu, J.-T.;Hsieh, J.-T.;Chang, H.-C.;Liao, S.-M.;Chou, C.-T.;Chiang, C.-K.;Chiu, W.-S.;Chiu, T.-Y.;Pu, Y.-S.;Ho, I.-L.;Wang, Z.-H.;Chang, S.-C.;Liu, S.-H.;Jeng, Y.-M.;Huang, K.-H.; WEI-CHOU LIN |
| 臺大學術典藏 |
2018-09-10T15:25:16Z |
Prognostic value of saturated prostate cryoablation for localized prostate cancer
|
Chen, C.-H.; Tai, Y.-S.; Pu, Y.-S.; Chen, Chung-Hsin; Tai, Yi-Sheng; Pu, Yeong-Shiau; 蒲永孝; 陳忠信; Chen, Chung-Hsin; CHUNG-HSIN CHEN; Pan, Kuo-Long; Tseng, Kun-Cheng; Tai, Yi-Sheng; YEONG-SHIAU PU; Wang, Ching-Hua; Pu, Yeong-Shiau |
| 臺大學術典藏 |
2018-09-10T07:45:19Z |
Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma
|
Huang, S.K. and Chiu, A.W.-H. and Pu, Y.-S. and Huang, Y.-K. and Chung, C.-J. and Tsai, H.-J. and Yang, M.-H. and Chen, C.-J. and Hsueh, Y.-M.; Huang, S.K.; Chiu, A.W.; Pu, Y.S.; Huang, Y.K.; Chung, C.J.; Tsai, H.J.; Yang, M.H.; Chen, C.J.; Hsueh, Y.M.; 黃冠華;邱文祥;蒲永孝;黃詠愷;鍾季容;蔡蕙如;楊末雄;陳建仁;薛玉梅; HUAN, STEVEN KUAN-HUA;CHIU, ALLEN WEN-HSIANG;PU, YEONG-SHIAU;HUANG, YUNG-KAI;CHUNG, CHI-JUNG;TSAI, HUI-JU;YANG, MO-HSIUNG;CHEN, CHIEN-JEN;HSUEH, YU-MEI; Chang, Chia-Hsuin; YEONG-SHIAU PU; Huang, S.K.; Chen, Hsi-Chieh; Chiu, A.W.; 邱文祥; Pu, Y.S.; Caffrey, James L.; Hsu, Jiun; Huang, Y.K.; Chung, C.J.; Lin, Jou-Wei; Tsai, H.J.; Lai, Mei-Shu; Yang, M.H.; Chen, Yih-Sharng; Chen, C.J.; 陳益祥; Hsueh, Y.M.; 賴美淑; HUAN, STEVEN KUAN-HUA; 張家勳; CHIU, ALLEN WEN-HSIANG; 張家豪; 許鈞; PU, YEONG-SHIAU; 林昭維; HUANG, YUNG-KAI; CHUNG, CHI-JUNG; TSAI, HUI-JU; YANG, MO-HSIUNG; CHEN, CHIEN-JEN; HSUEH, YU-MEI |
| 臺大學術典藏 |
2018-09-10T05:59:59Z |
Primary amyloidosis of the urinary bladder
|
Huang, C.-Y.;Shun, C.-T.;Huang, K.-H.;Chen, J.;Pu, Y.-S.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T05:59:58Z |
Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer
|
Hour, T.-C.;Pu, Y.-S.;Lin, C.-C.;Huang, S.-W.;Chen, J.;Chiu, A.W.;Chen, C.-J.;Huang, C.-Y.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T03:51:09Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen, A.-L.;Hsu, C.-H.;Lin, J.-K.;Hsu, M.-M.;Ho, Y.-F.;She, T.-S.;Ko, J.-Y.;Lin, J.-T.;Lin, B.-R.;Wu, M.-S.;Yu, H.-S.;Jee, S.-H.;Chen, G.-S.;Chen, T.-M.;Chen, C.-A.;Lai, M.-K.;Pu, Y.-S.;Pan, M.-H.;Wang, Y.-J.;Tsai, C.-C.;Hsieh, C.-Y.; SHIOU-HWA JEE |
| 臺大學術典藏 |
2018-09-10T03:48:44Z |
Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells
|
Pu, Y.-S.;Chen, J.;Huang, C.-Y.;Guan, J.-Y.;Lu, S.-H.;Hour, T.-C.; CHAO-YUAN HUANG |
顯示項目 566-590 / 627 (共26頁)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
每頁顯示[10|25|50]項目
|
